[Other forms of immunomodulation in allergic patients].
Cortegano
I
I
Servicio de Inmunología, Fundación Jiménez Díaz, Madrid, España.
Del Pozo
V
V
Rojo
M
M
Cárdaba
B
B
Aceituno
E
E
Gallardo
S
S
Mínguez
A
A
Arrieta
I
I
Palomino
P
P
Lahoz
C
C
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000485:Allergens / Q000008:administration & dosage / Q000627:therapeutic use; D000818:Animals; D018926:Anti-Allergic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000943:Antigens, Differentiation / Q000494:pharmacology / Q000627:therapeutic use; D015815:Cell Adhesion Molecules / Q000502:physiology; D018925:Chemokines / Q000037:antagonists & inhibitors*; D053818:Chymases; D016207:Cytokines / Q000037:antagonists & inhibitors*; D003888:Desensitization, Immunologic; D037502:Galectin 3; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology*; D007073:Immunoglobulin E / Q000276:immunology; D015847:Interleukin-4 / Q000037:antagonists & inhibitors; D015848:Interleukin-5 / Q000037:antagonists & inhibitors; D051379:Mice; D010446:Peptide Fragments / Q000008:administration & dosage / Q000627:therapeutic use; D012697:Serine Endopeptidases / Q000276:immunology; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D053802:Tryptases; D014611:Vaccination
D000276:Adjuvants, Immunologic; D000485:Allergens; D018926:Anti-Allergic Agents; D000943:Antigens, Differentiation; D015815:Cell Adhesion Molecules; D018925:Chemokines; D016207:Cytokines; D037502:Galectin 3; D015848:Interleukin-5; D010446:Peptide Fragments; D015842:Serine Proteinase Inhibitors; C509190:Tpsb2 protein, mouse; D015847:Interleukin-4; D007073:Immunoglobulin E; D012697:Serine Endopeptidases; C083294:chymase 2; D053818:Chymases; C509222:Tpsab1 protein, mouse; D053802:Tryptases
Otras formas de inmunomodulación en pacientes alérgicos.